A new pet for myeloma.
In this issue of Blood, Bartel and colleagues report the independent predictive value of the PET/CT and of the FDG suppression before transplantation in newly diagnosed myeloma patients who were treated using the TT3 regimen.
Dimopoulos
Meletios-Athanassios
MA
University of Athens.
Moulopoulos
Lia A
LA
Terpos
Evangelos
E